C
MXIM

Cerebellum’s Maxim Integrated Products MXIM Stock Holding History

Cerebellum’s Portfolio MXIM Stock Details MXIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,307
Closed -$121K – 627
2020
Q2 		$121K Buy
+2,307
New +$128K 0.09% 314
2019
Q4 		$566K Buy
9,205
+2,126
+30% +$124K 0.3% 54
2019
Q3 		$410K Buy
7,079
+1,383
+24% +$80.1K 0.26% 291
2019
Q2 		$341K Sell
5,696
-410
-7% -$23.4K 0.28% 236
2019
Q1 		$325K Buy
+6,106
New +$328K 0.28% 214
2018
Q4 		– Sell
-3,232
Closed -$182K – 559
2018
Q3 		$182K Buy
3,232
+261
+9% +$15.7K 0.29% 194
2018
Q2 		$174K Sell
2,971
-92
-3% -$5.36K 0.29% 188
2018
Q1 		$184K Buy
3,063
+756
+33% +$44.8K 0.24% 215
2017
Q4 		$121K Buy
+2,307
New +$120K 0.09% 314

Other funds holding MXIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cerebellum's MXIM Position: Q3 2020 in Review

Cerebellum sold out of Maxim Integrated Products (MXIM) in Q3 2020, closing a stake of 2,307 shares — an estimated $121K sold.

Cerebellum first reported a position in MXIM in Q4 2017 and held it in 9 quarters. The position peaked at $566K in Q4 2019. 598 funds tracked by Wall St. Rank hold MXIM as of Q3 2020.

  • Cerebellum reported no remaining Maxim Integrated Products position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 2,307 Maxim Integrated Products shares in Q3 2020, an estimated $121K.
  • Cerebellum first reported a position in Maxim Integrated Products in Q4 2017 and held it in 9 quarters.
  • Cerebellum's Maxim Integrated Products position peaked at $566K in Q4 2019.
  • 598 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.